Document is current
Any future updates will be listed below
-
Authors
Jiang, Tianlu
Zhou, Peng
Shen, Yikai
Lin, Jie
Li, Ying
Shen, Xusheng
Fang, Lang
Xu, Penghui
Xu, Zekuan
Wang, Linjun
Xia, Yiwen https://orcid.org/0009-0006-7636-4451
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No.82303168)
National Natural Science Foundation of China (No.82273038)
National Natural Science Foundation of China (No.82473292)
National Natural Science Foundation of China (No.82472936)
National Natural Science Foundation of China (82503303)
Natural Science Foundation of Jiangsu Province (No. BK20230736)
Natural Science Foundation of Jiangsu Province (No. BK20241984)
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University
- License Information
-
More Information
Article History
Received: 17 August 2025
Revised: 9 March 2026
Accepted: 23 March 2026
First Online: 9 April 2026
Declarations
:
: This study was approved by the Medical Ethics Committee of First Affiliated Hospital of Nanjing Medical University (2024-SR-557), and written informed consent was obtained from all participants. All procedures followed were in accordance with the ethical standards approved by Institutional Ethics Committee on human experimentation and with the Helsinki Declaration. Animal study was approved by the Animal Care and Use Committee of Nanjing Medical University (IACUC- 2408069) and was conducted in accordance with the National lnstitutes of Health guide for the care and use of Laboratory animals.
: Not applicable.
: The authors declare that they have no competing interests.
